Val66Met BDNF genotypes in melancholic depression: Effects on brain structure and treatment outcome

Depression and Anxiety

Volumn 30, Issue 3, 2013, Pages 225-233

  Cardoner, Narcís ^a,b,c   Soria, Virginia ^a,b   Gratacòs, Mònica ^d,e   Hernández Ribas, Rosa ^a,b   Pujol, Jesús ^f   Lõpez Solà, Marina ^f   Deus, Joan ^g   Urretavizcaya, Mikel ^a,b,c   Estivill, Xavier ^d,e   Menchõn, José M ^a,b,c   Soriano Mas, Carles ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

BDNF; brain morphometry; major depressive disorder; melancholic depression; neuroimaging; treatment outcome; Val66Met

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALINE;

ADULT; AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; FEMALE; GENOTYPE; GRAY MATTER; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VOXEL BASED MORPHOMETRY;

ADULT; AGED; AMINO ACID SUBSTITUTION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME; VALINE;

EID: 84874947859     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22025     Document Type: Article

References (62)

1. Aan het Rot M, Mathew SJ, Charney DS,. Neurobiological mechanisms in major depressive disorder. CMAJ 2009; 180: 305-313.
2. Scharinger C, Rabl U, Sitte HH, et al. Imaging genetics of mood disorders. Neuroimage 2010; 53: 810-821.
3. Parker G, Fink M, Shorter E, et al. Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry 2010; 167: 745-747.
4. Duman RS, Monteggia LM,. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
5. Castren E, Rantamaki T,. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010; 70: 289-297.
6. Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401-4411.
7. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
8. Gratacos M, Gonzalez JR, Mercader JM, et al. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007; 61: 911-922.
9. Verhagen M, van der Meij A, van Deurzen PA, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010; 15: 260-271.
10. Strauss J, Barr CL, George CJ, et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 2004; 131B: 16-19.
11. Schumacher J, Jamra RA, Becker T, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-314.
12. Licinio J, Dong C, Wong ML,. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 2009; 66: 488-497.
13. Choi MJ, Kang RH, Lim SW, et al. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176-182.
14. Yoshida K, Higuchi H, Kamata M, et al. The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine. J Psychopharmacol 2007; 21: 650-656.
15. Zou YF, Wang Y, Liu P, et al. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 2010; 61: 71-78.
16. Chi MH, Chang HH, Lee SY, et al. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder. J Affect Disord 2010; 126: 430-435.
17. Gratacos M, Soria V, Urretavizcaya M, et al. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J 2008; 8: 101-112.
18. Wilkie MJ, Smith D, Reid IC, et al. A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression. Pharmacogenet Genomics 2007; 17: 207-215.
19. Domschke K, Lawford B, Laje G, et al. Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 2010; 13: 93-101.
20. Uher R, Huezo-Diaz P, Perroud N, et al. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009; 9: 225-233.
21. Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-10102.
22. Szeszko PR, Lipsky R, Mentschel C, et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005; 10: 631-636.
23. Joffe RT, Gatt JM, Kemp AH, et al. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness. Hum Brain Mapp 2009; 30: 1246-1256.
24. Bueller JA, Aftab M, Sen S, et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006; 59: 812-815.
25. Montag C, Weber B, Fliessbach K, et al. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med 2009; 39: 1831-1839.
26. Nemoto K, Ohnishi T, Mori T, et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 2006; 397: 25-29.
27. MacQueen G, Frodl T,. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research ? Mol Psychiatry 2011; 16: 252-264.
28. Hickie I, Naismith S, Ward PB, et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry 2005; 186: 197-202.
29. Gold PW, Chrousos GP,. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002; 7: 254-275.
30. MacQueen GM,. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J Psychiatry Neurosci 2009; 34: 343-349.
31. Soriano-Mas C, Hernandez-Ribas R, Pujol J, et al. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol Psychiatry 2011; 69: 318-325.
32. Frodl T, Schule C, Schmitt G, et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007; 64: 410-416.
33. Gonul AS, Kitis O, Eker MC, et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J Biol Psychiatry 2011; 12: 110-118.
34. Kanellopoulos D, Gunning FM, Morimoto SS, et al. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry; 19: 13-22.
35. Benjamin S, McQuoid DR, Potter GG, et al. The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am J Geriatr Psychiatry 2010; 18: 323-331.
36. Cole J, Weinberger DR, Mattay VS, et al. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav 2011; 10: 756-764.
37. Jessen F, Schuhmacher A, von Widdern O, et al. No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression. Psychiatr Genet 2009; 19: 99-101.
38. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997.
39. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
40. Ashburner J, Friston KJ,. Unified segmentation. Neuroimage 2005; 26: 839-851.
41. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36.
42. Lieberman MD, Cunningham WA,. Type I and Type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 2009; 4: 423-428.
43. Frodl T, Moller HJ, Meisenzahl E,. Neuroimaging genetics: new perspectives in research on major depression ? Acta Psychiatr Scand 2008; 118: 363-372.
44. Savitz JB, Drevets WC,. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009; 164: 300-330.
45. Alexopoulos GS, Glatt CE, Hoptman MJ, et al. BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression. J Affect Disord 2010; 125: 262-268.
46. Taylor WD, McQuoid DR, Ashley-Koch A, et al. BDNF Val66Met genotype and 6-month remission rates in late-life depression. Pharmacogenomics J 2011; 11: 146-154.
47. Sheline YI, Mittler BL, Mintun MA,. The hippocampus and depression. Eur Psychiatry 2002; 17 (Suppl 3): 300-305.
48. Frodl T, Koutsouleris N, Bottlender R, et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 2008; 13: 1093-1101.
49. Frodl T, Reinhold E, Koutsouleris N, et al. Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res 2010; 44: 799-807.
50. Kanellopoulos D, Gunning FM, Morimoto SS, et al. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry 2011; 19: 13-22.
51. Casey BJ, Glatt CE, Tottenham N, et al. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience 2009; 164: 108-120.
52. Voineskos AN, Lerch JP, Felsky D, et al. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry 2011; 68: 198-206.
53. Drevets WC,. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 2007; 1121: 499-527.
54. Cardoner N, Soriano-Mas C, Pujol J, et al. Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder. Neuroimage 2007; 38: 413-421.
55. Delaveau P, Jabourian M, Lemogne C, et al. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. J Affect Disord 2011; 130: 66-74.
56. Drevets WC,. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001; 11: 240-249.
57. Eisch AJ, Bolanos CA, de Wit J, et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003; 54: 994-1005.
58. Boulle F, van den Hove DL, Jakob SB, et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 2012; 17: 584-596.
59. Shansky RM, Hamo C, Hof PR, et al. Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb Cortex 2009; 19: 2479-2484.
60. Liston C, Miller MM, Goldwater DS, et al. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 2006; 26: 7870-7874.
61. Pezawas L, Meyer-Lindenberg A, Goldman AL, et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 2008; 13: 709-716.
62. Paykel ES,. The interview for recent life events. Psychol Med 1997; 27: 301-310.